Stock Ticker

  • Loading stock data...

Amgen Inc. (NASDAQ:AMGN) Announces The Purchase of Immunology Drug Otezla from Celgene Corporation (NASDAQ:CELG)

Amgen Inc. (NASDAQ:AMGN) has announced the purchase of Celgene Corporation’s (NASDAQ:CELG) leading immunology drug Otezla for around $13.4 billion. Otezla purchase deal to be finalized at the end of the year The company has indicated that the deal will be closed at the end of the year. Following the announcement, Amgen’s stock gained 2.85% to […]

Sign Up To Get Our Latest Stocks Alerts